You are here

Novo Nordisk

Novo, Viking heat up MASH space with promising data at AASLD24

BioSpace

Wed, 11/20/24 - 11:40 am

Viking Therapeutics

Drugmakers and pharmacists battle over who gets to make obesity drugs

NPR

Wed, 11/20/24 - 11:21 am

compounded drugs

Novo’s Wegovy Launched in China at a Fraction of US Price

BioSpace

Mon, 11/18/24 - 11:28 am

Survey Finds Most GLP-1 Users Discontinue Drug Before Reaching Goal Weight

Xtalks

Fri, 11/15/24 - 11:27 am

Compounded Ozempic tied to deaths, hospitalizations: Novo Nordisk CEO

Beckers Hospital Review

Thu, 11/7/24 - 11:14 am

compounded drugs

FDA adds aspiration warning to Ozempic, Mounjaro and other GLP-1 labels

Beckers Hospital Review

Wed, 11/6/24 - 08:01 pm

Novo Nordisk discards kidney disease drug from $1.3B deal in wake of phase 3 fail

Fierce Biotech

Wed, 11/6/24 - 08:00 pm

clinical trials

Novo Nordisk Q3 earnings: Wegovy sales soar 79% year-over-year

Yahoo Finance

Wed, 11/6/24 - 11:44 am

States slow to cover GLP-1s for weight loss

Axios

Wed, 11/6/24 - 11:37 am

Wegovy reduces all-cause admissions: 3 study findings

Beckers Hospital Review

Mon, 11/4/24 - 11:19 am

hospital admissions

clinical trials

Novo pens $285M biobucks deal to use Ascendis' tech to create monthly GLP-1 agonist

Fierce Biotech

Mon, 11/4/24 - 11:13 am

Ascendis Pharma

drug development

Novo, with new results, to seek approval for obesity drug in MASH

BioPharma Dive

Fri, 11/1/24 - 11:25 am

Novo takes big step toward ending Ozempic, Wegovy shortages

BioPharma Dive

Wed, 10/30/24 - 08:48 pm

Backlash builds against Novo’s Catalent takeover

Pharma Voice

Wed, 10/30/24 - 11:40 am

Weight-loss drugs didn't curb health costs within two years

Reuters

Thu, 10/24/24 - 11:11 am

Lilly to launch its obesity drug in Denmark, Novo Nordisk's home market

Reuters

Thu, 10/24/24 - 09:53 am

Novo Nordisk's oral diabetes drug cuts heart-related risks by 14% in study

Reuters

Mon, 10/21/24 - 09:39 am

cardiovascular events

FDA’s GLP-1 decision kicks off ‘unprecedented’ tussle over shortage

Pharma Voice

Mon, 10/21/24 - 09:37 am

Chinese insulin maker says its GLP-1 beat Ozempic at lowering blood sugar, body weight in phase 2

Fierce Biotech

Wed, 10/16/24 - 12:17 pm

type 2 diabetes

Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch.

BioPharma Dive

Fri, 10/11/24 - 11:10 am

Skye Bioscience

Pages